The Trump administration has halted most of the Agency for Healthcare Research and Quality’s activities, stopping federal funding for over 100 grants aimed at improving patient safety and saving thousands of lives.
The Agency for Healthcare Research and Quality, a small Department of Health and Human Services agency, informed researchers of the grant halt in a July 15 letter, despite Congress appropriating $345 million for the agency this fiscal year. About 75% of the agency’s staff have been fired or quit since President Trump took office. The administration’s move has sparked criticism, with many arguing that the agency’s focus on patient safety aligns with Trump’s “Make American Healthy Again” campaign.
Healthcare Safety Grants
The Agency for Healthcare Research and Quality has played a crucial role in improving medical practice, saving billions of dollars, and preventing hospital infections. Researchers who received the letter expressed bewilderment, as their work overlaps with the agency’s stated priorities, including patient safety, preventing antibiotic resistance, and promoting digital health tools.
Experts, including Aaron Carroll, chief executive of AcademyHealth, and Hardeep Singh, director of the Houston Methodist Safety, Quality and Well-Being Institute, argue that the agency’s work is essential to addressing issues with the US healthcare system, such as high costs and inadequate treatment. The Trump administration’s changes to the agency appear to be permanent, with all grant managers fired and no clear plan for future grants.
Implications and Reactions
Researchers and experts are concerned about the long-term impact of the grant halt, citing the agency’s critical role in improving patient safety and reducing medical errors. The administration’s move has sparked criticism, with many arguing that it undermines the agency’s mission and the “Make American Healthy Again” campaign. HHS spokesperson Emily Hilliard stated that the agency intends to establish a new framework for grants, but provided no further details.
The halt in grants has significant implications for the healthcare system, with many arguing that it will lead to a decline in patient safety and an increase in medical errors. As the US healthcare system continues to grapple with issues of cost, quality, and accessibility, the Agency for Healthcare Research and Quality’s work is more critical than ever, and the administration’s decision to halt grants has sparked concerns about the future of patient safety in the US.
